The Latest Breaking News from Alzheimer Disease

Researchers say clinical trials are needed to determine the biological trajectory of Alzheimer’s disease

Analysis of blood samples finds women with the disease have 20% lower levels, a pattern not seen in men

People can get omega fatty acids as a supplement or by eating salmon, mackerel or sardines.

For nearly a decade, scientists from Harvard University have also been uncovering lithium’s unexpected importance in the brain

A new study could change the way we understand and treat dementia and other degenerative disorders of the brain

Over the past two centuries, vaccines have been critical for preventing infectious diseases. The World Health Organization estimates that vaccination prevents between 3 million and 5 million deaths annually from diseases like diphtheria, tetanus, influenza, measles and, more recently, COVID-19.

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion on Friday recommending Eli Lilly and Co.’s (NYSE:LLY) donanemab for early symptomatic Alzheimer’s disease in adults with confirmed amyloid pathology who are apolipoprotein E ε4 (ApoE4) heterozygotes or non-carriers.

Researchers say the findings provide new insights into possible early indicators of Alzheimer’s disease

One in three older Americans dies with Alzheimer's or another dementia

For years, scientists have assumed high levels of p-tau217 always spell trouble. The new research suggests they’ve been wrong

A protein long blamed for the brain damage seen in Alzheimer’s disease has now been found in astonishingly high levels in healthy newborn babies, challenging decades of medical dogma.